Pharmaceutical plasma protein formulations in low ionic strength

Details Pharmaceutical plasma protein formulations in low ionic strength Pharmaceutical plasma protein formulations in low ionic strength

1987-11-09

1989-10-31

Stone, Jacqueline M.

Drug, bio-affecting and body treating compositions

Lymphokine

424101, 514 2, 514 21, 514802, 514 8, A61K 39395, A61K 3516, A61K 3718

Patent

active

048776084

ABSTRACT:
Stable factor VIII and other plasma protein formulations are provided in low ionic strength media which comprises: sodium chloride, potassium chloride or mixtures thereof; lysine hydrochloride; and histidine as the buffering agent.

REFERENCES:
patent: Re32011 (1985-10-01), Zimmerman et al.
patent: 4089944 (1978-05-01), Thomas
patent: 4104266 (1978-08-01), Wickerhouser
patent: 4188318 (1980-02-01), Shanbrom
patent: 4321192 (1982-03-01), Jain

Affiliated with

Also associated with

Rating

Pharmaceutical plasma protein formulations in low ionic strength does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical plasma protein formulations in low ionic strength, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical plasma protein formulations in low ionic strength will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-624632